GLAND PHARMA
Back to Income Statement
|
GLAND PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹4,348 Cr | ₹4,332 Cr | ₹2,600 Cr | ₹2,891 Cr | ₹2,161 Cr |
What is the latest Total Expenditure of GLAND PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹4,348 Cr |
| Mar2025 | ₹4,332 Cr |
| Mar2024 | ₹2,600 Cr |
| Mar2023 | ₹2,891 Cr |
| Mar2022 | ₹2,161 Cr |
How is Total Expenditure of GLAND PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,348 Cr | 0.37 | |
| Mar2025 | ₹4,332 Cr | 66.61 | |
| Mar2024 | ₹2,600 Cr | -10.06 | |
| Mar2023 | ₹2,891 Cr | 33.78 | |
| Mar2022 | ₹2,161 Cr | - | |
Compare Total Expenditure of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹46,536.6 Cr | -3% | 18.6% | 43% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3% |
18.6% |
43% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses